$13.08
At close: Apr 14, 4:00 PM EDT
$13.08
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Dentsply Sirona Analyst Ratings and Price Targets | NASDAQ:XRAY | Benzinga
Dentsply Sirona Inc has a consensus price target of $27.23 based on the ratings of 17 analysts. The high is $49 issued by B of A Securities on April 20, 2022. The low is $18 issued by Mizuho on March 13, 2025. The 3 most-recent analyst ratings were released by Mizuho, Wells Fargo, and Barrington Research on March 13, 2025, February 28, 2025, and February 28, 2025, respectively. With an average price target of $19 between Mizuho, Wells Fargo, and Barrington Research, there's an implied 45.26% upside for Dentsply Sirona Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Mizuho
Wells Fargo
Barrington Research
Baird
Jefferies
1calculated from analyst ratings
Analyst Ratings for Dentsply Sirona
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/13/2025 | Buy Now | 37.61% | Mizuho | Steven Valiquette59% | $21 → $18 | Maintains | Neutral | Get Alert |
| 03/13/2025 | Buy Now | — | Needham | David Saxon51% | — | Downgrade | Buy → Hold | Get Alert |
| 02/28/2025 | Buy Now | 45.26% | Wells Fargo | Vik Chopra39% | $20 → $19 | Maintains | Equal-Weight | Get Alert |
| 02/28/2025 | Buy Now | 52.91% | Barrington Research | Michael Petusky48% | $24 → $20 | Maintains | Outperform | Get Alert |
| 02/28/2025 | Buy Now | 52.91% | Baird | Jeffrey Johnson40% | $22 → $20 | Maintains | Neutral | Get Alert |
| 02/28/2025 | Buy Now | 75.84% | Needham | David Saxon51% | $25 → $23 | Maintains | Buy | Get Alert |
| 02/14/2025 | Buy Now | 52.91% | Wells Fargo | Vik Chopra39% | → $20 | Initiates | → Equal-Weight | Get Alert |
| 02/11/2025 | Buy Now | 91.13% | Needham | David Saxon51% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 01/30/2025 | Buy Now | 91.13% | Needham | David Saxon51% | $23 → $25 | Maintains | Buy | Get Alert |
| 01/23/2025 | Buy Now | 52.91% | Jefferies | Glen Santangelo50% | $30 → $20 | Downgrade | Buy → Hold | Get Alert |
| 01/07/2025 | Buy Now | 52.91% | Evercore ISI Group | Elizabeth Anderson44% | → $20 | Downgrade | Outperform → In-Line | Get Alert |
| 12/17/2024 | Buy Now | 75.84% | Morgan Stanley | Erin Wright75% | $30 → $23 | Maintains | Overweight | Get Alert |
| 12/04/2024 | Buy Now | 60.55% | Mizuho | Steven Valiquette59% | → $21 | Initiates | → Neutral | Get Alert |
| 12/03/2024 | Buy Now | 106.42% | UBS | Kevin Caliendo73% | $35 → $27 | Maintains | Buy | Get Alert |
| 11/08/2024 | Buy Now | 83.49% | Barrington Research | Michael Petusky48% | $36 → $24 | Maintains | Outperform | Get Alert |
| 11/08/2024 | Buy Now | 83.49% | Baird | Jeffrey Johnson40% | $31 → $24 | Maintains | Neutral | Get Alert |
| 11/07/2024 | Buy Now | — | Leerink Partners | Michael Cherny78% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/28/2024 | Buy Now | 121.71% | Needham | David Saxon51% | $34 → $29 | Maintains | Buy | Get Alert |
| 10/08/2024 | Buy Now | 106.42% | Evercore ISI Group | Elizabeth Anderson44% | $29 → $27 | Maintains | Outperform | Get Alert |
| 09/20/2024 | Buy Now | 175.23% | Barrington Research | Michael Petusky48% | $36 → $36 | Maintains | Outperform | Get Alert |
| 08/20/2024 | Buy Now | 159.94% | Needham | David Saxon51% | $34 → $34 | Reiterates | Buy → Buy | Get Alert |
| 07/31/2024 | Buy Now | 159.94% | Needham | David Saxon51% | $36 → $34 | Maintains | Buy | Get Alert |
| 07/22/2024 | Buy Now | 137% | Baird | Jeffrey Johnson40% | $33 → $31 | Maintains | Neutral | Get Alert |
| 07/18/2024 | Buy Now | 114.07% | Stifel | Jonathan Block71% | $30 → $28 | Maintains | Hold | Get Alert |
| 07/09/2024 | Buy Now | 106.42% | Evercore ISI Group | Elizabeth Anderson44% | $28 → $27 | Maintains | Outperform | Get Alert |
| 07/08/2024 | Buy Now | 190.52% | Barrington Research | Michael Petusky48% | $38 → $38 | Maintains | Outperform | Get Alert |
| 06/25/2024 | Buy Now | 114.07% | Evercore ISI Group | Elizabeth Anderson44% | $35 → $28 | Maintains | Outperform | Get Alert |
| 05/06/2024 | Buy Now | 129.36% | Goldman Sachs | Nathan Rich44% | $34 → $30 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | 167.58% | Evercore ISI Group | Elizabeth Anderson44% | $40 → $35 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | 190.52% | Barrington Research | Michael Petusky48% | $41 → $38 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | 144.65% | Piper Sandler | Jason Bednar52% | $35 → $32 | Reiterates | Neutral → Neutral | Get Alert |
| 05/03/2024 | Buy Now | 152.29% | Baird | Jeffrey Johnson40% | $35 → $33 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | 175.23% | Needham | David Saxon51% | $42 → $36 | Maintains | Buy | Get Alert |
| 04/18/2024 | Buy Now | 213.46% | Barrington Research | Michael Petusky48% | $41 → $41 | Maintains | Outperform | Get Alert |
| 03/01/2024 | Buy Now | 213.46% | Barrington Research | Michael Petusky48% | → $41 | Reiterates | Outperform → Outperform | Get Alert |
| 02/29/2024 | Buy Now | 221.1% | Needham | David Saxon51% | $42 → $42 | Reiterates | Buy → Buy | Get Alert |
| 02/26/2024 | Buy Now | 221.1% | Leerink Partners | Michael Cherny78% | → $42 | Initiates | → Outperform | Get Alert |
| 01/12/2024 | Buy Now | 167.58% | Piper Sandler | Jason Bednar52% | $31 → $35 | Maintains | Neutral | Get Alert |
| 01/09/2024 | Buy Now | 221.1% | Needham | David Saxon51% | $35 → $42 | Maintains | Buy | Get Alert |
| 11/16/2023 | Buy Now | 167.58% | Needham | David Saxon51% | → $35 | Initiates | → Buy | Get Alert |
| 11/13/2023 | Buy Now | 144.65% | Stifel | Jonathan Block71% | $35 → $32 | Maintains | Hold | Get Alert |
| 11/10/2023 | Buy Now | — | William Blair | Brandon Vazquez55% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 11/07/2023 | Buy Now | 175.23% | Goldman Sachs | Nathan Rich44% | $42 → $36 | Maintains | Neutral | Get Alert |
| 11/03/2023 | Buy Now | 213.46% | Barrington Research | Michael Petusky48% | $51 → $41 | Maintains | Outperform | Get Alert |
| 11/03/2023 | Buy Now | 198.17% | Morgan Stanley | Erin Wright75% | $43 → $39 | Maintains | Overweight | Get Alert |
| 11/01/2023 | Buy Now | 167.58% | Stifel | Jonathan Block71% | $41 → $35 | Maintains | Hold | Get Alert |
| 10/20/2023 | Buy Now | 228.75% | Morgan Stanley | Erin Wright75% | $47 → $43 | Maintains | Overweight | Get Alert |
| 09/22/2023 | Buy Now | 198.17% | Piper Sandler | Jason Bednar52% | $42 → $39 | Maintains | Neutral | Get Alert |
| 08/04/2023 | Buy Now | 289.91% | Barrington Research | Michael Petusky48% | → $51 | Reiterates | → Outperform | Get Alert |
| 05/04/2023 | Buy Now | 289.91% | Barrington Research | Michael Petusky48% | $43 → $51 | Reiterates | → Outperform | Get Alert |
| 05/04/2023 | Buy Now | 213.46% | Stifel | Jonathan Block71% | $37 → $41 | Maintains | Hold | Get Alert |
| 05/04/2023 | Buy Now | 259.33% | Morgan Stanley | Erin Wright75% | $45 → $47 | Maintains | Overweight | Get Alert |
| 05/04/2023 | Buy Now | 251.68% | Baird | Jeffrey Johnson40% | $36 → $46 | Maintains | Neutral | Get Alert |
| 04/19/2023 | Buy Now | 244.04% | Morgan Stanley | Erin Wright75% | $39 → $45 | Maintains | Overweight | Get Alert |
| 03/02/2023 | Buy Now | 198.17% | Goldman Sachs | Nathan Rich44% | $34 → $39 | Maintains | Neutral | Get Alert |
| 03/01/2023 | Buy Now | 198.17% | Goldman Sachs | Nathan Rich44% | $34 → $39 | Maintains | Neutral | Get Alert |
| 02/06/2023 | Buy Now | 167.58% | Piper Sandler | Jason Bednar52% | $29 → $35 | Maintains | Neutral | Get Alert |
| 01/12/2023 | Buy Now | — | William Blair | Brandon Vazquez55% | — | Upgrade | Underperform → Market Perform | Get Alert |
| 11/16/2022 | Buy Now | 159.94% | Goldman Sachs | Nathan Rich44% | $41 → $34 | Maintains | Neutral | Get Alert |
| 11/15/2022 | Buy Now | 198.17% | Morgan Stanley | Erin Wright75% | $42 → $39 | Maintains | Overweight | Get Alert |
| 10/13/2022 | Buy Now | 221.1% | Morgan Stanley | Erin Wright75% | $44 → $42 | Maintains | Overweight | Get Alert |
| 08/05/2022 | Buy Now | — | William Blair | John Kreger52% | — | Downgrade | Market Perform → Underperform | Get Alert |
| 07/21/2022 | Buy Now | 213.46% | Goldman Sachs | Nathan Rich44% | $42 → $41 | Maintains | Neutral | Get Alert |
| 07/20/2022 | Buy Now | 236.39% | Morgan Stanley | Erin Wright75% | $48 → $44 | Maintains | Overweight | Get Alert |
| 06/02/2022 | Buy Now | 259.33% | UBS | Kevin Caliendo73% | $58 → $47 | Upgrade | Neutral → Buy | Get Alert |
| 05/11/2022 | Buy Now | 266.97% | Morgan Stanley | Erin Wright75% | $52 → $48 | Maintains | Overweight | Get Alert |
| 04/22/2022 | Buy Now | 266.97% | HC Wainwright & Co. | Yi Chen54% | $58 → $48 | Maintains | Neutral | Get Alert |
| 04/21/2022 | Buy Now | 259.33% | Goldman Sachs | Nathan Rich44% | $59 → $47 | Maintains | Neutral | Get Alert |
| 04/20/2022 | Buy Now | 297.55% | Morgan Stanley | Erin Wright75% | $62 → $52 | Maintains | Overweight | Get Alert |
| 04/20/2022 | Buy Now | 274.62% | B of A Securities | Michael Cherny78% | $66 → $49 | Downgrade | Buy → Neutral | Get Alert |
| 04/20/2022 | Buy Now | 251.68% | Piper Sandler | Jason Bednar52% | $71 → $46 | Downgrade | Overweight → Neutral | Get Alert |
| 04/19/2022 | Buy Now | — | William Blair | John Kreger52% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 04/19/2022 | Buy Now | 266.97% | Baird | Jeffrey Johnson40% | → $48 | Downgrade | Outperform → Neutral | Get Alert |
| 04/19/2022 | Buy Now | — | B of A Securities | Michael Cherny78% | — | Downgrade | Buy → Neutral | Get Alert |
FAQ
What is the target price for Dentsply Sirona (XRAY) stock?
The latest price target for Dentsply Sirona (NASDAQ:XRAY) was reported by Mizuho on March 13, 2025. The analyst firm set a price target for $18.00 expecting XRAY to rise to within 12 months (a possible 37.61% upside). 34 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Dentsply Sirona (XRAY)?
The latest analyst rating for Dentsply Sirona (NASDAQ:XRAY) was provided by Mizuho, and Dentsply Sirona maintained their neutral rating.
When was the last upgrade for Dentsply Sirona (XRAY)?
The last upgrade for Dentsply Sirona Inc happened on November 10, 2023 when William Blair raised their price target to N/A. William Blair previously had a market perform for Dentsply Sirona Inc.
When was the last downgrade for Dentsply Sirona (XRAY)?
The last downgrade for Dentsply Sirona Inc happened on March 13, 2025 when Needham changed their price target from N/A to N/A for Dentsply Sirona Inc.
When is the next analyst rating going to be posted or updated for Dentsply Sirona (XRAY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dentsply Sirona, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dentsply Sirona was filed on March 13, 2025 so you should expect the next rating to be made available sometime around March 13, 2026.
Is the Analyst Rating Dentsply Sirona (XRAY) correct?
While ratings are subjective and will change, the latest Dentsply Sirona (XRAY) rating was a maintained with a price target of $21.00 to $18.00. The current price Dentsply Sirona (XRAY) is trading at is $13.08, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.